BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 30772825)

  • 21. Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989-2007.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    J Cancer Res Clin Oncol; 2008 Dec; 134(12):1277-87. PubMed ID: 18506484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of different treatment modalities on survival of patients with low-grade endometrial stromal sarcoma: A retrospective cohort study.
    Zhou J; Zheng H; Wu SG; He ZY; Li FY; Su GQ; Sun JY
    Int J Surg; 2015 Nov; 23(Pt A):147-51. PubMed ID: 26449652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment options in stage I endometrial stromal sarcoma: a retrospective analysis of 53 cases.
    Li N; Wu LY; Zhang HT; An JS; Li XG; Ma SK
    Gynecol Oncol; 2008 Feb; 108(2):306-11. PubMed ID: 18061249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Uterine sarcoma in Tunisia: retrospective study about 14 cases].
    Bouzid N; Kanoun Belajouza S; Boussen H; Bouaouina N
    Gynecol Obstet Fertil; 2014 Dec; 42(12):838-43. PubMed ID: 25155830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors in undifferentiated uterine sarcoma: a subanalysis of the SARCUT study.
    Macuks R; Yildirim Y; Mancari R; Achimas-Cadariu P; Madhuri TK; Ortega E; Mallmann M; Zivanovic O; Zapardiel I;
    Arch Gynecol Obstet; 2023 Sep; 308(3):981-988. PubMed ID: 37193821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors, oncological treatment and outcomes of uterine sarcoma: 10 years' clinical experience from a tertiary care center in Pakistan.
    Khan SR; Soomar SM; Asghari T; Ahmed A; Moosajee MS
    BMC Cancer; 2023 Jun; 23(1):510. PubMed ID: 37277708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian preservation in stage I low-grade endometrial stromal sarcomas.
    Li AJ; Giuntoli RL; Drake R; Byun SY; Rojas F; Barbuto D; Klipfel N; Edmonds P; Miller DS; Karlan BY
    Obstet Gynecol; 2005 Dec; 106(6):1304-8. PubMed ID: 16319256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
    Kuku S; Williams M; McCormack M
    Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors, treatment and outcome in a Turkish population with endometrial stromal sarcoma.
    Donertas A; Nayki U; Nayki C; Ulug P; Gultekin E; Yildirim Y
    Asian Pac J Cancer Prev; 2015; 16(3):881-7. PubMed ID: 25735377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uterine sarcoma Part II-Uterine endometrial stromal sarcoma: The TAG systematic review.
    Horng HC; Wen KC; Wang PH; Chen YJ; Yen MS; Ng HT;
    Taiwan J Obstet Gynecol; 2016 Aug; 55(4):472-9. PubMed ID: 27590366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor.
    Burghaus S; Halmen S; Gass P; Mehlhorn G; Schrauder MG; Lux MP; Renner SP; Beckmann MW; Hein A; Thiel FC
    Arch Gynecol Obstet; 2016 Aug; 294(2):343-51. PubMed ID: 26711836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic treatment in adult uterine sarcomas.
    Desar IME; Ottevanger PB; Benson C; van der Graaf WTA
    Crit Rev Oncol Hematol; 2018 Feb; 122():10-20. PubMed ID: 29458779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endometrial stromal sarcoma of twenty cases.
    Huang KT; Chen CA; Tseng GC; Chen TM; Cheng WF; Hsieh CY
    Acta Obstet Gynecol Scand; 1996 Jul; 75(6):551-5. PubMed ID: 8693932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
    Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
    Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovary and uterus-sparing procedures for low-grade endometrial stromal sarcoma: a retrospective study of 153 cases.
    Bai H; Yang J; Cao D; Huang H; Xiang Y; Wu M; Cui Q; Chen J; Lang J; Shen K
    Gynecol Oncol; 2014 Mar; 132(3):654-60. PubMed ID: 24412112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors and outcome of undifferentiated endometrial sarcoma treated by multimodal therapy.
    Malouf GG; Lhommé C; Duvillard P; Morice P; Haie-Meder C; Pautier P
    Int J Gynaecol Obstet; 2013 Jul; 122(1):57-61. PubMed ID: 23597861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-grade endometrial stromal sarcoma in a 16-year-old girl.
    Michalas S; Creatsas G; Deligeoroglou E; Markaki S
    Gynecol Oncol; 1994 Jul; 54(1):95-8. PubMed ID: 8020847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
    Zhu J; Wen H; Bi R; Wu X
    J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Undifferentiated uterine sarcoma: a rare, not well known and aggressive disease: report of 13 cases.
    Ríos I; Rovirosa A; Morales J; Gonzalez-Farre B; Arenas M; Ordi J; Pahisa J; Biete A
    Arch Gynecol Obstet; 2014 Nov; 290(5):993-7. PubMed ID: 24958349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does radiotherapy or lymphadenectomy improve survival in endometrial stromal sarcoma?
    Barney B; Tward JD; Skidmore T; Gaffney DK
    Int J Gynecol Cancer; 2009 Oct; 19(7):1232-8. PubMed ID: 19823060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.